Inhibitors of the interactions between collagen and its receptors on platelets

Handbook of Experimental Pharmacology

Volumn 210, Issue , 2012, Pages 311-337

  Deckmyn, Hans ^a   De Meyer, Simon F ^a   Broos, Katleen ^a   Vanhoorelbeke, Karen ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Collagens; Glycoprotein VI; Integrin 2 1; Platelet collagen receptors

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; CALIN; CLOPIDOGREL; COLLAGEN; COLLAGEN INHIBITOR; COLLAGEN RECEPTOR; COLLAGEN TYPE I PLATELET RECEPTOR; COLLAGEN TYPE III PLATELET RECEPTOR; DZ 697B; EXP 3179; GLYCOPROTEIN V; GLYCOPROTEIN VI; GLYCOPROTEIN VI INHIBITOR; HEAT SHOCK PROTEIN 47; IMMUNOGLOBULIN F(AB) FRAGMENT; INTEGRIN ALPHA 2 BETA 1 INHIBITOR; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY JAQ1; PLATELET TYPE III COLLAGEN BINDING PROTEIN; PROTEIN INHIBITOR; SALVIANOLIC ACID B; SARATIN; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY 10B12; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY 1C3; SNAKE VENOM; THROMBOCYTE RECEPTOR; UNCLASSIFIED DRUG; UNINDEXED DRUG; VERY LATE ACTIVATION ANTIGEN 2; FIBRINOGEN RECEPTOR; PLATELET MEMBRANE GLYCOPROTEIN VI;

ARTERY THROMBOSIS; ARTICLE; BLEEDING DISORDER; BLEEDING TIME; CAROTID ARTERY INJURY; DOSE RESPONSE; DRUG MECHANISM; FEMORAL VEIN THROMBOSIS; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LIGAND BINDING; LIGAND SPECIFICITY; MOLECULAR PATHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; RISK ASSESSMENT; THROMBOCYTE; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION INHIBITION; THROMBOEMBOLISM; THROMBOSIS; VEIN THROMBOSIS; AMINO ACID SEQUENCE; ANIMAL; CHEMISTRY; DRUG ANTAGONISM; MOLECULAR GENETICS; PHYSIOLOGY; REVIEW;

AMINO ACID SEQUENCE; ANIMALS; COLLAGEN; HUMANS; INTEGRIN ALPHA2BETA1; MOLECULAR SEQUENCE DATA; PLATELET AGGREGATION INHIBITORS; PLATELET MEMBRANE GLYCOPROTEINS; THROMBOSIS;

EID: 84867144287     PISSN: 01712004     EISSN: 18650325     Source Type: Book Series    
DOI: 10.1007/978-3-642-29423-5_13     Document Type: Article

References (138)

1. Arthur JF, Dunkley S, Andrews RK (2007b) Platelet glycoprotein VI-related clinical defects. Br J Haematol 139:363-372
2. Arthur JF, Shen Y, Kahn ML, Berndt MC, Andrews RK, Gardiner EE (2007a) Ligand binding rapidly induces disulfide-dependent dimerization of glycoprotein VI on the platelet plasma membrane. J Biol Chem 282:30434-30441
3. Barnes CS, Krafft B, Frech M, Hofmann UR, Papendieck A, Dahlems U, Gellissen G, Hoylaerts MF (2001) Production and characterization of saratin, an inhibitor of von Willebrand factordependent platelet adhesion to collagen. Semin Thromb Hemost 27:337-348
4. Bender M, Hofmann S, Stegner D, Chalaris A, Bosl M, Braun A, Scheller J, Rose-John S, Nieswandt B (2010) Differentially regulated GPVI ectodomain shedding by multiple platelet-expressed proteinases. Blood 116:3347-3355
5. Berlanga O, Bori-Sanz T, James JR, Frampton J, Davis SJ, Tomlinson MG, Watson SP (2007) Glycoprotein VI oligomerization in cell lines and platelets. J Thromb Haemost 5:1026-1033
6. Bigalke B, Stellos K, Weig HJ, Geisler T, Seizer P, Kremmer E, Potz O, Joos T, May AE, Lindemann S, Gawaz M (2009) Regulation of platelet glycoprotein VI (GPVI) surface expression and of soluble GPVI in patients with atrial fibrillation (AF) and acute coronary syndrome (ACS). Basic Res Cardiol 104:352-357
7. Bigalke B, Stellos K, Geisler T, Kremmer E, Seizer P, May AE, Lindemann S, Melms A, Luft A, Gawaz M (2010a) Expression of platelet glycoprotein VI is associated with transient ischemic attack and stroke. Eur J Neurol 17:111-117
8. Bigalke B, Stellos K, Geisler T, Lindemann S, May AE, Gawaz M (2010b) Glycoprotein VI as a prognostic biomarker for cardiovascular death in patients with symptomatic coronary artery disease. Clin Res Cardiol 99:227-233
9. Bigalke B, Lindemann S, Ehlers R, Seizer P, Daub K, Langer H, Schonberger T, Kremmer E, Siegel-Axel D, May AE, Gawaz M (2006) Expression of platelet collagen receptor glycoprotein VI is associated with acute coronary syndrome. Eur Heart J 27:2165-2169
10. Bigalke B, Geisler T, Stellos K, Langer H, Daub K, Kremmer E, Seizer P, May AE, Lindemann S, GawazM(2008) Platelet collagen receptor glycoprotein VI as a possible novel indicator for the acute coronary syndrome. Am Heart J 156:193-200
11. Boilard E, Nigrovic PA, Larabee K, Watts GF, Coblyn JS, Weinblatt ME, Massarotti EM, Remold-O'Donnell E, Farndale RW, Ware J, Lee DM (2010) Platelets amplify inflammation in arthritis via collagen-dependent microparticle production. Science 327:580-583
12. Bultmann A, Li Z, Wagner S, Peluso M, Schonberger T, Weis C, Konrad I, Stellos K, Massberg S, Nieswandt B, Gawaz M, Ungerer M, Munch G (2010) Impact of glycoprotein VI and platelet adhesion on atherosclerosis-a possible role of fibronectin. J Mol Cell Cardiol 49:532-542
13. Calvo E, Tokumasu F, Mizurini DM, McPhie P, Narum DL, Ribeiro JM, Monteiro RQ, Francischetti IM (2010) Aegyptin displays high-affinity for the von Willebrand factor binding site (RGQOGVMGF) in collagen and inhibits carotid thrombus formation in vivo. FEBS J 277:413-427
14. Carlsson LE, Santoso S, Spitzer C, Kessler C, Greinacher A (1999) The alpha2 gene coding sequence T807/A873 of the platelet collagen receptor integrin alpha2beta1 might be a genetic risk factor for the development of stroke in younger patients. Blood 93:3583-3586
15. Chadderdon RC, Cappello M (1999) The hookworm platelet inhibitor: functional blockade of integrins GPIIb/IIIa (alphaIIbbeta3) and GPIa/IIa (alpha2beta1) inhibits platelet aggregation and adhesion in vitro. J Infect Dis 179:1235-1241
16. Cheng TO (2007) Cardiovascular effects of Danshen. Int J Cardiol 121:9-22
17. Chiang TM, Cole F, Woo-Rasberry V (2002) Cloning, characterization, and functional studies of a 47-kDa platelet receptor for type III collagen. J Biol Chem 277:34896-34901
18. Chiang TM, Kang AH (1997) A synthetic peptide derived from the sequence of a type I collagen receptor inhibits type I collagen-mediated platelet aggregation. J Clin Invest 100:2079-2084
19. Chiang TM, Rinaldy A, Kang AH (1997) Cloning, characterization, and functional studies of a nonintegrin platelet receptor for type I collagen. J Clin Invest 100:514-521
20. Chiang TM, Seyer JM, Kang AH (1993) Collagen-platelet interaction: separate receptor sites for types I and III collagen. Thromb Res 71:443-456
21. Clemetson JM, Polgar J, Magnenat E, Wells TN, Clemetson KJ (1999) The platelet collagen receptor glycoprotein VI is a member of the immunoglobulin superfamily closely related to FcalphaR and the natural killer receptors. J Biol Chem 274:29019-29024
22. Coller BS, Beer JH, Scudder LE, Steinberg MH (1989) Collagen-platelet interactions: evidence for a direct interaction of collagen with platelet GPIa/IIa and an indirect interaction with platelet GPIIb/IIIa mediated by adhesive proteins. Blood 74:182-192
23. Connolly TM, Jacobs JW, Condra C (1992) An inhibitor of collagen-stimulated platelet activation from the salivary glands of the Haementeria officinalis leech. I. Identification, isolation, and characterization. J Biol Chem 267:6893-6898
24. Croft SA, Samani NJ, Hampton KK, Steeds RP, Channer KS, Daly ME (2001) Novel platelet membrane glycoprotein VI dimorphism is a risk factor for myocardial infarction. Circulation 104:1459-1463
25. Cruz CP, Eidt J, Drouilhet J, Brown AT, Wang Y, Barnes CS, Moursi MM (2001) Saratin, an inhibitor of von Willebrand factor-dependent platelet adhesion, decreases platelet aggregation and intimal hyperplasia in a rat carotid endarterectomy model. J Vasc Surg 34:724-729
26. Daniel JL, Dangelmaier C, Strouse R, Smith JB (1994) Collagen induces normal signal transduction in platelets deficient in CD36 (platelet glycoprotein IV). Thromb Haemost 71:353-356
27. Deckmyn H, Chew SL, Vermylen J (1990) Lack of platelet response to collagen associated with an autoantibody against glycoprotein Ia: a novel cause of acquired qualitative platelet dysfunction. Thromb Haemost 64:74-79
28. Deckmyn H, Stassen JM, Vreys I, Van Houtte E, Sawyer RT, Vermylen J (1995) Calin from Hirudo medicinalis, an inhibitor of platelet adhesion to collagen, prevents platelet-rich thrombosis in hamsters. Blood 85:712-719
29. Depraetere H, Kerekes A, Deckmyn H (1999) The collagen-binding leech products rLAPP and calin prevent both von Willebrand factor and alpha2beta1(GPIa/IIa)-I-domain binding to collagen in a different manner. Thromb Haemost 82:1160-1163
30. Diaz-Ricart M, Tandon NN, Carretero M, Ordinas A, Bastida E, Jamieson GA (1993) Platelets lacking functional CD36 (glycoprotein IV) show reduced adhesion to collagen in flowing whole blood. Blood 82:491-496
31. Djaafri I, Maurice P, Labas V, Vinh J, Lemesle M, Arbeille B, Legrand C, Mourah S, Fauvel- Lafeve F (2011) Platelet type III collagen binding protein (TIIICBP) presents high biochemical and functional similarities with kindlin-3. Biochimie 94(2):416-426
32. Du H, Zawaski JA, Gaber MW, Chiang TM (2007) A recombinant protein and a chemically synthesized peptide containing the active peptides of the platelet collagen receptors inhibit ferric chloride-induced thrombosis in a rat model. Thromb Res 121:419-426
33. Dubois C, Panicot-Dubois L, Merrill-Skoloff G, Furie B, Furie BC (2006) Glycoprotein VIdependent and -independent pathways of thrombus formation in vivo. Blood 107:3902-3906
34. Dumont B, Lasne D, Rothschild C, Bouabdelli M, Ollivier V, Oudin C, Ajzenberg N, Grandchamp B, Jandrot-Perrus M (2009) Absence of collagen-induced platelet activation caused by compound heterozygous GPVI mutations. Blood 114:1900-1903
35. Eble JA, Beermann B, Hinz HJ, Schmidt-Hederich A (2001) alpha 2beta 1 integrin is not recognized by rhodocytin but is the specific, high affinity target of rhodocetin, an RGDindependent disintegrin and potent inhibitor of cell adhesion to collagen. J Biol Chem 276:12274-12284
36. Eble JA, Tuckwell DS (2003) The alpha2beta1 integrin inhibitor rhodocetin binds to the A-domain of the integrin alpha2 subunit proximal to the collagen-binding site. Biochem J 376:77-85
37. Eble JA, Bruckner P, Mayer U (2003) Vipera lebetina venom contains two disintegrins inhibiting laminin-binding beta1 integrins. J Biol Chem 278:26488-26496
38. Echtler K, Stark K, Lorenz M, Kerstan S, Walch A, Jennen L, Rudelius M, Seidl S, Kremmer E, Emambokus NR, von BruehlML, Frampton J, Isermann B, Genzel-Boroviczeny O, Schreiber C, Mehilli J, Kastrati A, Schwaiger M, Shivdasani RA, Massberg S (2010) Platelets contribute to postnatal occlusion of the ductus arteriosus. Nat Med 16:75-82
39. Emsley J, Knight CG, Farndale RW, Barnes MJ (2004) Structure of the integrin alpha2beta1- binding collagen peptide. J Mol Biol 335:1019-1028
40. Emsley J, Knight CG, Farndale RW, Barnes MJ, Liddington RC (2000) Structural basis of collagen recognition by integrin alpha2beta1. Cell 101:47-56
41. Emsley J, King SL, Bergelson JM, Liddington RC (1997) Crystal structure of the I domain from integrin alpha2beta1. J Biol Chem 272:28512-28517
42. Estavillo D, Ritchie A, Diacovo TG, Cruz MA (1999) Functional analysis of a recombinant glycoprotein Ia/IIa (Integrin alpha(2)beta(1)) I domain that inhibits platelet adhesion to collagen and endothelial matrix under flow conditions. J Biol Chem 274:35921-35926
43. Furihata K, Nugent DJ, Kunicki TJ (2002) Influence of Platelet Collagen Receptor Polymorphisms on Risk for Arterial Thrombosis. Arch Pathol Lab Med 126:305-309
44. Gronwald W, Bomke J, Maurer T, Domogalla B, Huber F, Schumann F, Kremer W, Fink F, Rysiok T, Frech M, Kalbitzer HR (2008) Structure of the leech protein saratin and characterization of its binding to collagen. J Mol Biol 381:913-927
45. Grothusen C, Umbreen S, Konrad I, Stellos K, Schulz C, Schmidt B, Kremmer E, Teebken O, Massberg S, Luchtefeld M, Schieffer B, Gawaz M (2007) EXP3179 inhibits collagendependent platelet activation via glycoprotein receptor-VI independent of AT1-receptor antagonism: potential impact on atherothrombosis. Arterioscler Thromb Vasc Biol 27:1184-1190
46. Gruner S, Prostredna M, Koch M, Miura Y, Schulte V, Jung SM, Moroi M, Nieswandt B (2005) Relative antithrombotic effect of soluble GPVI dimer compared with anti-GPVI antibodies in mice. Blood 105:1492-1499
47. Gruner S, Prostredna M, Schulte V, Krieg T, Eckes B, Brakebusch C, Nieswandt B (2003) Multiple integrin-ligand interactions synergize in shear-resistant platelet adhesion at sites of arterial injury in vivo. Blood 102:4021-4027
48. Han JY, Fan JY, Horie Y, Miura S, Cui DH, Ishii H, Hibi T, Tsuneki H, Kimura I (2008) Ameliorating effects of compounds derived from Salvia miltiorrhiza root extract on microcirculatory disturbance and target organ injury by ischemia and reperfusion. Pharmacol Ther 117:280-295
49. Handa M, Watanabe K, Kawai Y, Kamata T, Koyama T, Nagai H, Ikeda Y (1995) Platelet unresponsiveness to collagen: involvement of glycoprotein Ia- IIa (alpha 2 beta 1 integrin) deficiency associated with a myeloproliferative disorder. Thromb Haemost 73:521-528
50. Harsfalvi J, Stassen JM, Hoylaerts MF, Van Houtte E, Sawyer RT, Vermylen J, Deckmyn H (1995) Calin from Hirudo medicinalis, an inhibitor of von Willebrand factor binding to collagen under static and flow conditions. Blood 85:705-711
51. Hebert C, Norris K, Della CR, Reynolds M, Ordonez J, Sauk JJ (1999) Cell surface colligin/Hsp47 associates with tetraspanin protein CD9 in epidermoid carcinoma cell lines. J Cell Biochem 73:248-258
52. He L, Pappan LK, Grenache DG, Li ZZ, Tollefsen DM, Santoro SA, Zutter MM (2003) The contributions of the alpha(2)beta(1) integrin to vascular thrombosis in vivo. Blood 102:3652-3657
53. Hechler B, Nonne C, Eckly A, Magnenat S, Rinckel JY, Denis CV, Freund M, Cazenave JP, Lanza F, Gachet C (2010) Arterial thrombosis: relevance of a model with two levels of severity assessed by histologic, ultrastructural and functional characterization. J Thromb Haemost 8:173-184
54. Hermans C, Wittevrongel C, Thys C, Smethurst PA, Van GC, Freson K (2009) A compound heterozygous mutation in glycoprotein VI in a patient with a bleeding disorder. J Thromb Haemost 7:1356-1363
55. Herr AB, Farndale RW (2009) Structural insights into the interactions between platelet receptors and fibrillar collagen. J Biol Chem 284:19781-19785
56. Hirano K, Kuwasako T, Nakagawa-Toyama Y, Janabi M, Yamashita S, Matsuzawa Y (2003) Pathophysiology of human genetic CD36 deficiency. Trends Cardiovasc Med 13:136-141
57. Holtkotter O, Nieswandt B, Smyth N, Muller W, Hafner M, Schulte V, Krieg T, Eckes B (2002) Integrin alpha 2-deficient mice develop normally, are fertile, but display partially defective platelet interaction with collagen. J Biol Chem 277:10789-10794
58. Horii K, Kahn ML, Herr AB (2006) Structural basis for platelet collagen responses by the immunetype receptor glycoprotein VI. Blood 108:936-942
59. Hovig T (1963) Aggregation of rabbit blood platelets produced in vitro by saline extract of tendons. Thromb Diath Haemorrh 143:248-263
60. Hsu CC, Wu WB, Huang TF (2008) A snake venom metalloproteinase, kistomin, cleaves platelet glycoprotein VI and impairs platelet functions. J Thromb Haemost 6:1578-1585
61. Inoue O, Suzuki-Inoue K, McCarty OJ, Moroi M, Ruggeri ZM, Kunicki TJ, Ozaki Y, Watson SP (2006) Laminin stimulates spreading of platelets through integrin alpha6beta1-dependent activation of GPVI. Blood 107:1405-1412
62. Jandrot-Perrus M, Busfield S, Lagrue AH, Xiong X, Debili N, Chickering T, Le Couedic JP, Goodearl A, Dussault B, Fraser C, Vainchenker W, Villeval JL (2000) Cloning, characterization, and functional studies of human and mouse glycoprotein VI: a platelet-specific collagen receptor from the immunoglobulin superfamily. Blood 96:1798-1807
63. Jarvis GE, Raynal N, Langford JP, Onley DJ, Andrews A, Smethurst PA, Farndale RW (2008) Identification of a major GpVI-binding locus in human type III collagen. Blood 111:4986-4996
64. Joutsi-Korhonen L, Smethurst PA, Rankin A, Gray E, Ijsseldijk M, Onley CM, Watkins NA, Williamson LM, Goodall AH, de Groot PG, Famdale RW, Ouwehand WH (2003) The lowfrequency allele of the platelet collagen signaling receptor glycoprotein VI is associated with reduced functional responses and expression. Blood 101:4372-4379
65. Jung SM, Moroi M (2000) Signal-transducing mechanisms involved in activation of the platelet collagen receptor integrin alpha(2)beta(1). J Biol Chem 275:8016-8026
66. Jung SM, Tsuji K, MoroiM(2009) Glycoprotein (GP) VI dimer as a major collagen-binding site of native platelets: direct evidence obtained with dimeric GPVI-specific Fabs. J Thromb Haemost 7:1347-1355
67. Kaiser WJ, Holbrook LM, Tucker KL, Stanley RG, Gibbins JM (2009) A functional proteomic method for the enrichment of peripheral membrane proteins reveals the collagen binding protein Hsp47 is exposed on the surface of activated human platelets. J Proteome Res 8:2903-2914
68. Kamata T, Puzon W, Takada Y (1994) Identification of putative ligand binding sites within I domain of integrin alpha 2 beta 1 (VLA-2, CD49b/CD29). J Biol Chem 269:9659-9663
69. Kamiguti AS, Markland FS, Zhou Q, Laing GD, Theakston RD, Zuzel M (1997) Proteolytic cleavage of the beta1 subunit of platelet alpha2beta1 integrin by the metalloproteinase jararhagin compromises collagen-stimulated phosphorylation of pp72. J Biol Chem 272:32599-32605
70. Kapyla J, Pentikainen OT, Nyronen T, Nissinen L, Lassander S, Jokinen J, Lahti M, Marjamaki A, Johnson MS, Heino J (2007) Small molecule designed to target metal binding site in the alpha2I domain inhibits integrin function. J Med Chem 50:2742-2746
71. Kato K, Kanaji T, Russell S, Kunicki TJ, Furihata K, Kanaji S, Marchese P, Reininger A, Ruggeri ZM, Ware J (2003) The contribution of glycoprotein VI to stable platelet adhesion and thrombus formation illustrated by targeted gene deletion. Blood 102:1701-1707
72. Keller PM, Schultz LD, Condra C, Karczewski J, Connolly TM (1992) An inhibitor of collagenstimulated platelet activation from the salivary glands of the Haementeria officinalis leech. II. Cloning of the cDNA and expression. J Biol Chem 267:6899-6904
73. Kirchhofer D, Languino LR, Ruoslahti E, Pierschbacher MD (1990) Alpha 2 beta 1 integrins from different cell types show different binding specificities. J Biol Chem 265:615-618
74. Kleinschnitz C, Pozgajova M, Pham M, Bendszus M, Nieswandt B, Stoll G (2007) Targeting platelets in acute experimental stroke: impact of glycoprotein Ib, VI, and IIb/IIIa blockade on infarct size, functional outcome, and intracranial bleeding. Circulation 115:2323-2330
75. Konishi H, Katoh Y, Takaya N, Kashiwakura Y, Itoh S, Ra C, Daida H (2002) Platelets activated by collagen through immunoreceptor tyrosine-based activation motif play pivotal role in initiation and generation of neointimal hyperplasia after vascular injury. Circulation 105:912-916
76. Konstantinides S, Ware J, Marchese P, mus-Jacobs F, Loskutoff DJ, Ruggeri ZM (2006) Distinct antithrombotic consequences of platelet glycoprotein Ibalpha and VI deficiency in a mouse model of arterial thrombosis. J Thromb Haemost 4:2014-2021
77. Kritzik M, Savage B, Nugent DJ, Santoso S, Ruggeri ZM, Kunicki TJ (1998) Nucleotide polymorphisms in the alpha2 gene define multiple alleles that are associated with differences in platelet alpha2 beta1 density. Blood 92:2382-2388
78. Kuijpers MJ, Pozgajova M, Cosemans JM, Munnix IC, Eckes B, Nieswandt B, Heemskerk JW (2007) Role of murine integrin alpha2beta1 in thrombus stabilization and embolization: contribution of thromboxane A2. Thromb Haemost 98:1072-1080
79. Kumar MS, Girish KS, Vishwanath BS, Kemparaju K (2011) The metalloprotease, NN-PF3 from Naja naja venom inhibits platelet aggregation primarily by affecting alpha2beta1 integrin. Ann Hematol 90:569-577
80. Kunicki TJ, Orchekowski R, Annis D, Honda Y (1993) Variability of integrin alpha 2 beta 1 activity on human platelets. Blood 82:2693-2703
81. Lebbink RJ, de RT, Adelmeijer J, Brenkman AB, van Helvoort JM, Koch M, Farndale RW, Lisman T, Sonnenberg A, Lenting PJ, Meyaard L (2006) Collagens are functional, high affinity ligands for the inhibitory immune receptor LAIR-1. J Exp Med 203:1419-1425
82. Lecut C, Feeney LA, Kingsbury G, Hopkins J, Lanza F, Gachet C, Villeval JL, Jandrot-Perrus M (2003) Human platelet glycoprotein VI function is antagonized by monoclonal anti bodyderived Fab fragments. J Thromb Haemost 1:2653-2662
83. Lenting PJ, Westerlaken GH, Denis CV, Akkerman JW, Meyaard L (2010) Efficient inhibition of collagen-induced platelet activation and adhesion by LAIR-2, a soluble Ig-like receptor family member. PLoS One 5:e12174
84. Li H, Lockyer S, Concepcion A, Gong X, Takizawa H, Guertin M, Matsumoto Y, Kambayashi J, Tandon NN, Liu Y (2007) The Fab fragment of a novel anti-GPVI monoclonal antibody, OM4, reduces in vivo thrombosis without bleeding risk in rats. Arterioscler Thromb Vasc Biol 27:1199-1205
85. Locke D, Chen H, Liu Y, Liu C, Kahn ML (2002) Lipid rafts orchestrate signaling by the platelet receptor glycoprotein VI. J Biol Chem 277:18801-18809
86. Lockyer S, Okuyama K, Begum S, Le S, Sun B, Watanabe T, Matsumoto Y, Yoshitake M, Kambayashi J, Tandon NN (2006) GPVI-deficient mice lack collagen responses and are protected against experimentally induced pulmonary thromboembolism. Thromb Res 118:371-380
87. Luo BH, Carman CV, Springer TA (2007) Structural basis of integrin regulation and signaling. Annu Rev Immunol 25:619-647
88. Mangin P, Yap CL, Nonne C, Sturgeon SA, Goncalves I, Yuan Y, Schoenwaelder SM, Wright CE, Lanza F, Jackson SP (2006) Thrombin overcomes the thrombosis defect associated with platelet GPVI/FcRgamma deficiency. Blood 107:4346-4353
89. Massberg S, Konrad I, Bultmann A, Schulz C, Munch G, Peluso M, Lorenz M, Schneider S, Besta F, Muller I, Hu B, Langer H, Kremmer E, Rudelius M, Heinzmann U, Ungerer M, Gawaz M (2004) Soluble glycoprotein VI dimer inhibits platelet adhesion and aggregation to the injured vessel wall in vivo. FASEB J 18:397-399
90. Massberg S, Gawaz M, Gruner S, Schulte V, Konrad I, Zohlnhofer D, Heinzmann U, Nieswandt B (2003) A crucial role of glycoprotein VI for platelet recruitment to the injured arterial wall in vivo. J Exp Med 197:41-49
91. Matsumoto Y, Takizawa H, Nakama K, Gong X, Yamada Y, Tandon NN, Kambayashi J (2006) Ex vivo evaluation of anti-GPVI antibody in cynomolgus monkeys: dissociation between antiplatelet aggregatory effect and bleeding time. Thromb Haemost 96:167-175
92. Maurice P, Pires V, Amant C, Kauskot A, Da NS, Sonnet P, Rochette J, Legrand C, Fauvel-Lafeve F, Bonnefoy A (2006) Antithrombotic effect of the type III collagen-related octapeptide (KOGEOGPK) in the mouse. Vascul Pharmacol 44:42-49
93. Miller MW, Basra S, Kulp DW, Billings PC, Choi S, Beavers MP, McCarty OJ, Zou Z, Kahn ML, Bennett JS, DeGrado WF (2009) Small-molecule inhibitors of integrin alpha2beta1 that prevent pathological thrombus formation via an allosteric mechanism. Proc Natl Acad Sci U S A 106:719-724
94. Miyaishi O, Sakata K, Matsuyama M, Saga S (1992) Distribution of the collagen binding heatshock protein in chicken tissues. J Histochem Cytochem 40:1021-1029
95. Monnet E, Fauvel-Lafeve F (2000) A new platelet receptor specific to type III collagen. Type III collagen-binding protein. J Biol Chem 275:10912-10917
96. Monnet E, Depraetere H, Legrand C, Deckmyn H, Fauvel-Lafeve F (2001) A monoclonal antibody to platelet type III collagen-binding protein (TIIICBP) binds to blood and vascular cells, and inhibits platelet vessel-wall interactions. Thromb Haemost 86:694-701
97. Moog S, Mangin P, Lenain N, Strassel C, Ravanat C, Schuhler S, Freund M, Santer M, Kahn M, Nieswandt B, Gachet C, Cazenave JP, Lanza F (2001) Platelet glycoprotein V binds to collagen and participates in platelet adhesion and aggregation. Blood 98:1038-1046
98. Moshfegh K, Wuillemin WA, Redondo M, Lammle B, Beer JH, Liechti-Gallati S, Meyer BJ (1999) Association of two silent polymorphisms of platelet glycoprotein Ia/IIa receptor with risk of myocardial infarction: a case-control study. Lancet 353:351-354
99. Moura-da-Silva AM, Ramos OH, Baldo C, Niland S, Hansen U, Ventura JS, Furlan S, Butera D, la-Casa MS, Tanjoni I, Clissa PB, Fernandes I, Chudzinski-Tavassi AM, Eble JA (2008) Collagen binding is a key factor for the hemorrhagic activity of snake venom metalloproteinases. Biochimie 90:484-492
100. Muzard J, Bouabdelli M, Zahid M, Ollivier V, Lacapere JJ, Jandrot-Perrus M, Billiald P (2009) Design and humanization of a murine scFv that blocks human platelet glycoprotein VI in vitro. FEBS J 276:4207-4222
101. Nieswandt B, Brakebusch C, Bergmeier W, Schulte V, Bouvard D, Mokhtari-Nejad R, Lindhout T, Heemskerk JW, Zirngibl H, Fassler R (2001b) Glycoprotein VI but not alpha2beta1 integrin is essential for platelet interaction with collagen. EMBO J 20:2120-2130
102. Nieswandt B, Schulte V, Bergmeier W, Mokhtari-Nejad R, Rackebrandt K, Cazenave JP, Ohlmann P, Gachet C, Zirngibl H (2001a) Long-term antithrombotic protection by in vivo depletion of platelet glycoprotein VI in mice. J Exp Med 193:459-469
103. Nieuwenhuis HK, Akkerman JW, Houdijk WP, Sixma JJ (1985) Human blood platelets showing no response to collagen fail to express surface glycoprotein Ia. Nature 318:470-472
104. Nissinen L, Pentikainen OT, Jouppila A, Kapyla J, Ojala M, Nieminen J, Lipsanen A, Lappalainen H, Eckes B, Johnson MS, Lassila R, Marjamaki A, Heino J (2010) A small-molecule inhibitor of integrin alpha2 beta1 introduces a new strategy for antithrombotic therapy. Thromb Haemost 103:387-397
105. Ollikainen E, Mikkelsson J, Perola M, Penttila A, Karhunen PJ (2004) Platelet membrane collagen receptor glycoprotein VI polymorphism is associated with coronary thrombosis and fatal myocardial infarction in middle-aged men. Atherosclerosis 176:95-99
106. Pentikainen O, Hoffren AM, Ivaska J, Kapyla J, Nyronen T, Heino J, Johnson MS (1999) "RKKH" peptides from the snake venom metalloproteinase of Bothrops jararaca bind near the metal iondependent adhesion site of the human integrin alpha(2) I-domain. J Biol Chem 274:31493-31505
107. Penz S, Reininger AJ, Brandl R, Goyal P, Rabie T, Bernlochner I, Rother E, Goetz C, Engelmann B, Smethurst PA, Ouwehand WH, Farndale R, Nieswandt B, Siess W (2005) Human atheromatous plaques stimulate thrombus formation by activating platelet glycoprotein VI. FASEB J 19:898-909
108. Pugh N, Simpson AM, Smethurst PA, de Groot PG, Raynal N, Farndale RW (2010) Synergism between platelet collagen receptors defined using receptor-specific collagen-mimetic peptide substrata in flowing blood. Blood 115:5069-5079
109. Quek LS, Pasquet JM, Hers I, Cornall R, Knight G, Barnes M, Hibbs ML, Dunn AR, Lowell CA, Watson SP (2000) Fyn and Lyn phosphorylate the Fc receptor gamma chain downstream of glycoprotein VI in murine platelets, and Lyn regulates a novel feedback pathway. Blood 96:4246-4253
110. Rabie T, Strehl A, Ludwig A, Nieswandt B (2005) Evidence for a role of ADAM17 (TACE) in the regulation of platelet glycoprotein V. J Biol Chem 280:14462-14468
111. Raynal N, Hamaia SW, Siljander PRM, Maddox B, Peachey AR, Fernandez R, Foley LJ, Slatter DA, Jarvis GE, Farndale RW (2006) Use of synthetic peptides to locate novel integrin alpha(2) beta(1)-binding motifs in human collagen III. J Biol Chem 281:3821-3831
112. Riba R, Hughes CE, Graham A, Watson SP, Naseem KM (2008) Globular adiponectin induces platelet activation through the collagen receptor GPVI-Fc receptor gamma chain complex. J Thromb Haemost 6:1012-1020
113. Saelman EU, Nieuwenhuis HK, Hese KM, de Groot PG, Heijnen HF, Sage EH, Williams S, McKeown L, Gralnick HR, Sixma JJ (1994) Platelet adhesion to collagen types I through VIII under conditions of stasis and flow is mediated by GPIa/IIa (alpha 2 beta 1-integrin). Blood 83:1244-1250
114. Santoso S, Kunicki TJ, Kroll H, Haberbosch W, Gardemann A (1999) Association of the platelet glycoprotein Ia C807T gene polymorphism with nonfatal myocardial infarction in younger patients. Blood 93:2449-2453
115. Sato S, Futaki F, Fukuchi N, Kaida K, Hiraga M, Kobaru S, Tsuji T (2006) A new nucleoside derivative, AJP117510, as an inhibitor of integrin alpha2beta1-collagen binding. J Antibiot (Tokyo) 59:251-253
116. Schaffer LW, Davidson JT, Siegl PK, Gould RJ, Nutt RF, Brady SF, Connolly TM (1993) Recombinant leech antiplatelet protein prevents collagen-mediated platelet aggregation but not collagen graft thrombosis in baboons. Arterioscler Thromb 13:1593-1601
117. Schmaier AA, Zou Z, Kazlauskas A, Emert-Sedlak L, Fong KP, Neeves KB, Maloney SF, Diamond SL, Kunapuli SP, Ware J, Brass LF, Smithgall TE, Saksela K, Kahn ML (2009) Molecular priming of Lyn by GPVI enables an immune receptor to adopt a hemostatic role. Proc Natl Acad Sci USA 106:21167-21172
118. Schulte V, Reusch HP, Pozgajova M, Varga-Szabo D, Gachet C, Nieswandt B (2006) Two-phase antithrombotic protection after anti-glycoprotein VI treatment in mice. Arterioscler Thromb Vasc Biol 26:1640-1647
119. Siljander PRM, Munnix ICA, Smethurst PA, Deckmyn H, Lindhout T, Ouwehand WH, Farndale RW, Heemskerk JWM (2004) Platelet receptor interplay regulates collagen-induced thrombus formation in flowing human blood. Blood 103:1333-1341
120. Smethurst PA, Onley DJ, Jarvis GE, O'Connor MN, Knight CG, Herr AB, Ouwehand WH, Farndale RW (2007) Structural basis for the platelet-collagen interaction: the smallest motif within collagen that recognizes and activates platelet Glycoprotein VI contains two glycineproline- hydroxyproline triplets. J Biol Chem 282:1296-1304
121. Smethurst PA, Joutsi-Korhonen L, O'Connor MN, Wilson E, Jennings NS, Garner SF, Zhang Y, Knight CG, Dafforn TR, Buckle A, Ijsseldijk MJ, de Groot PG, Watkins NA, Farndale RW, Ouwehand WH (2004) Identification of the primary collagen-binding surface on human glycoprotein VI by site-directed mutagenesis and by a blocking phage antibody. Blood 103:903-911
122. Sugiyama T, Okuma M, Ushikubi F, Sensaki S, Kanaji K, Uchino H (1987) A novel platelet aggregating factor found in a patient with defective collagen-induced platelet aggregation and autoimmune thrombocytopenia. Blood 69:1712-1720
123. Suzuki-Inoue K, Tulasne D, Shen Y, Bori-Sanz T, Inoue O, Jung SM, Moroi M, Andrews RK, Berndt MC, Watson SP (2002) Association of Fyn and Lyn with the proline-rich domain of glycoprotein VI regulates intracellular signaling. J Biol Chem 277:21561-21566
124. Takayama H, Hosaka Y, Nakayama K, Shirakawa K, Naitoh K, Matsusue T, Shinozaki M, Honda M, Yatagai Y, Kawahara T, Hirose J, Yokoyama T, Kurihara M, Furusako S (2008) A novel antiplatelet antibody therapy that induces cAMP-dependent endocytosis of the GPVI/Fc receptor gamma-chain complex. J Clin Invest 118:1785-1795
125. Tanjoni I, Evangelista K, la-Casa MS, Butera D, Magalhaes GS, Baldo C, Clissa PB, Fernandes I, Eble J, Moura-da-Silva AM (2010) Different regions of the class P-III snake venom metalloproteinase jararhagin are involved in binding to alpha2beta1 integrin and collagen. Toxicon 55:1093-1099
126. Verkleij MW, Ijsseldijk MJ, Heijnen-Snyder GJ, Huizinga EG, Morton LF, Knight CG, Sixma JJ, de Groot PG, Barnes MJ (1999) Adhesive domains in the collagen III fragment alpha1(III)CB4 that support alpha2beta1- and von Willebrand factor-mediated platelet adhesion under flow conditions. Thromb Haemost 82:1137-1144
127. Verkleij MW, Morton LF, Knight CG, de Groot PG, Barnes MJ, Sixma JJ (1998) Simple collagenlike peptides support platelet adhesion under static but not under flow conditions: interaction via alpha2 beta1 and von Willebrand factor with specific sequences in native collagen is a requirement to resist shear forces. Blood 91:3808-3816
128. Vilahur G, Duran X, Juan-Babot O, Casani L, Badimon L (2004) Antithrombotic effects of saratin on human atherosclerotic plaques. Thromb Haemost 92:191-200
129. Walker A, Pugh N, Garner SF, Stephens J, Maddox B, Ouwehand WH, Farndale RW, Steward M (2009) Single domain antibodies against the collagen signalling receptor glycoprotein VI are inhibitors of collagen induced thrombus formation. Platelets 20:268-276
130. Wang WJ, Shih CH, Huang TF (2005) Primary structure and antiplatelet mechanism of a snake venom metalloproteinase, acurhagin, from Agkistrodon acutus venom. Biochimie 87:1065-1077
131. Watson SP, Auger JM, McCarty OJ, Pearce AC (2005) GPVI and integrin alphaIIb beta3 signaling in platelets. J Thromb Haemost 3:1752-1762
132. Wijeyewickrema LC, Gardiner EE, Moroi M, Berndt MC, Andrews RK (2007) Snake venom metalloproteinases, crotarhagin and alborhagin, induce ectodomain shedding of the platelet collagen receptor, glycoprotein VI. Thromb Haemost 98:1285-1290
133. Wonerow P, Obergfell A, Wilde JI, Bobe R, Asazuma N, Brdicka T, Leo A, Schraven B, Horejsi V, Shattil SJ, Watson SP (2002) Differential role of glycolipid-enriched membrane domains in glycoprotein VI- and integrin-mediated phospholipase Cgamma2 regulation in platelets. Biochem J 364:755-765
134. Wu YP, Zhao XM, Pan SD, Guo dA, Wei R, Han JJ, Kainoh M, Xia ZL, de Groot PG, Lisman T (2008) Salvianolic acid B inhibits platelet adhesion under conditions of flow by a mechanism involving the collagen receptor alpha2beta1. Thromb Res 123:298-305
135. Yin H, Gerlach LO, Miller MW, Moore DT, Liu D, Vilaire G, Bennett JS, DeGrado WF (2006) Arylamide derivatives as allosteric inhibitors of the integrin alpha2beta1/type I collagen interaction. Bioorg Med Chem Lett 16:3380-3382
136. Zafar MU, Ibanez B, Choi BG, Vorchheimer DA, Pinero A, Jin X, Sharma RK, Badimon JJ (2010) A new oral antiplatelet agent with potent antithrombotic properties: comparison of DZ-697b with clopidogrel a randomised phase I study. Thromb Haemost 103:205-212
137. Zhu J, Cole F, Woo-Rasberry V, Fang XR, Chiang TM (2007) Type I and type III collagen-platelet interaction: inhibition by type specific receptor peptides. Thromb Res 119:111-119
138. Zucker MB, Borrelli J (1961) Platelet viscous metamorphosis produced by connective tissue particles. Fed Proc 20:61